What's in ZARS Pharma Inc.'s pipeline?

ZARS Pharma Inc. has 5 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with ZARS Pharma Inc.'s portfolio?

Top competitors by shared drug class: Depomed, Dong-A ST Co., Ltd., Handok Inc., Imprimis Pharmaceuticals, Inc., Kunming Baker Norton Pharmaceutical Sales Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/zars-pharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

ZARS Pharma Inc. — Portfolio Competitive Intelligence Brief

ZARS Pharma Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Placebo Matrix/CHADD Patch	Placebo Matrix/CHADD Patch	phase 3
Placebo Peel	Placebo Peel	phase 3
Ketoprofen matrix/placebo CHADD Patch	Ketoprofen matrix/placebo CHADD Patch	phase 3	NSAID (nonsteroidal anti-inflammatory drug)	COX-1, COX-2	Pain Management / Rheumatology

Therapeutic area mix

Pain Management / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Depomed · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Handok Inc. · 1 shared drug class
Imprimis Pharmaceuticals, Inc. · 1 shared drug class
Kunming Baker Norton Pharmaceutical Sales Co., Ltd. · 1 shared drug class
LEO Pharma · 1 shared drug class
Novartis · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ZARS Pharma Inc.:

Cite this brief

Drug Landscape (2026). ZARS Pharma Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/zars-pharma-inc. Accessed 2026-05-14.